Chemical Design & Synthesis Unit, Abbott Healthcare Products B.V., C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands.
Eur J Med Chem. 2011 Oct;46(10):5086-98. doi: 10.1016/j.ejmech.2011.08.021. Epub 2011 Aug 23.
The discovery, synthesis and structure-activity relationship (SAR) of a novel series of cannabinoid 1 (CB(1)) and cannabinoid 2 (CB(2)) receptor ligands are reported. Based on the aminoalkylindole class of cannabinoid receptor agonists, a biphenyl moiety was introduced as novel lipophilic indole 3-acyl substituent in 11-16. Furthermore, the 3-carbonyl tether was replaced with a carboxamide linker in 17-20 and the azaindole (pyrrolopyridine) nucleus was designed as indole bioisostere with improved physicochemical properties in 21-25. Through these SAR efforts, several high affinity CB(1)/CB(2) dual cannabinoid receptor ligands were identified. Indole-3-carboxamide 17 displayed single-digit nanomolar affinity and ~80 fold selectivity for CB(1) over the CB(2) receptor. The azaindoles displayed substantially improved physicochemical properties (lipophilicity; aqueous solubility). Azaindole 21 elicited potent cannabinoid activity. Cannabinoid receptor agonists 17 and 21 potently modulated excitatory synaptic transmission in an acute rat brain slice model of cannabinoid receptor-modulated neurotransmission.
报告了一系列新型大麻素 1(CB1)和大麻素 2(CB2)受体配体的发现、合成和构效关系(SAR)。基于氨基烷基吲哚类大麻素受体激动剂,在 11-16 中引入了联苯部分作为新型亲脂性吲哚 3-酰基取代基。此外,在 17-20 中用羧酰胺连接体取代了 3-羰基键,并在 21-25 中设计了氮杂吲哚(吡咯并吡啶)核作为吲哚的生物等排体,改善了理化性质。通过这些 SAR 研究,确定了几种高亲和力的 CB1/CB2 双大麻素受体配体。吲哚-3-甲酰胺 17 对 CB1 受体的亲和力为纳摩尔级,对 CB2 受体的选择性为 80 倍。氮杂吲哚显示出显著改善的理化性质(亲脂性;水溶解度)。氮杂吲哚 21 表现出很强的大麻素活性。大麻素受体激动剂 17 和 21 在急性大鼠脑片模型中有效调节大麻素受体调节的神经传递中的兴奋性突触传递。